CCL2 and neoplasm: Further, by inhibiting transcription in the tumour associated macrophages, lurbinectedin downregulates immune-suppressive cytokines such as interleukin-6 (IL-6), interleukin-8 (IL-8), C-C motif chemokine 2 (CCL2) and VEGF [77].